Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Category 3

Growth

Depth and Timing of Hypoglycaemia Achieved During Insulin Tolerance Test in Children
aDevelopmental Endocrinology Research Group, Royal Hospital for Sick Children, Glasgow, UK; bDepartment of Biochemistry, Southern General Hospital Laboratory, Glasgow, UK
hrp0084p3-1007
Presenting Characteristics, Auxological, and Aetiologic Evaluation of 364 Patients with GH Deficiency
aPaediatric Endocrinology, Diyarbakir Children’s State Hospital, Diyarbakir, Turkey; bPaediatric Endocrinology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey; cPaediatrics, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey; dDepartments of Paediatric Endocrinology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
hrp0084p3-1008
Nutritional Supplementation, Sleep Patterns and Growth in Short and Lean Prepubertal Children
aInstitute for Endocrinology and Diabetes, Schneider Children’s Medical of Israel, Petah Tikva, Israel; bSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; cInstitute for Gastroenterology, Nutrition, and Liver Diseases, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
hrp0084p3-1009
Disease-Specific Growth Charts of Marfan Syndrome in Korea
aDepartment of Pediatrcis, Myongji Hospital, Goyang, Republic of Korea; bDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; cDepartment of Medical Genetics, Ajou University Hospital, Suwon, Republic of Korea; dDepartment of Pediatrics, Jeil Hospital, Kwandong University School of Medicine, Seoul, Republic of Korea
hrp0084p3-1010
Case Report of Wolf-Hirschhorn Syndrome by Chromosomal Microarray Analysis: Importance of the Molecular Investigation for the Aetiological Diagnosis of Short Stature
aReplicon Research Group, Pontifical Catholic University of Goias, Goiânia, Brazil; bGenetics Master’s Program, Pontifical Catholic University of Goias, Goiânia, Brazil; cSecretary of Goias State for Public Health, Human Cytogenetics and Molecular Genetics Laboratory, Goiânia, Goiás, Brazil
hrp0084p3-1012
Achondroplasia Reference as Background Matrix for Following Children with Extreme Short Stature
aDepartment for Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; bPaediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden; cUniversity of Southern Denmark, Odense, Denmark; dOdense University Hospital, Odense, Denmark
hrp0084p3-1013
Altered Gene-Expression in Human Growth Plate Cartilage Tissue Exposed to Dexamethasone
Department of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden
hrp0084p3-1014
Reversible GH Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma
Pediatric Department, Royal Marsden NHS Foundation Trust, London, UK
hrp0084p3-1015
Autosomal Recessive Omodysplasia: A Rare Cause of Disproportionate Short Stature
aHospital Materno Infantil Presidente Vargas (HMIPV), Porto Alegre, Brazil; bUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil
hrp0084p3-1016
The Growth Characteristics of Patients with Noonan Syndrome, and First 2 Years Results of GH Treatment: A Nationwide Multicentre Study
aFaculty of Medicine, Ankara University, Ankara, Turkey; bIstanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; cDr Sami Ulus Child Health and Disease Training and Research Hospital, Ankara, Turkey; dFaculty of Medicine, Marmara University, Istanbul, Turkey; eFaculty of Medicine, Ondokuzmayis University, Samsun, Turkey; fDepartment of Pediatric Endocrinology and Diabetes, Konya Training and Research Hospital, Konya, Turkey; gFaculty of Medicine, Eylül University, Izmir, Turkey; hGulhane Military Medicine Academy, Ankara, Turkey; iFaculty of Medicine, Duzce University, Duzce, Turkey; jIzmir Dr Behcet Uz Children Disease and Surgery Training and Research Hospital, Izmir, Turkey; kFaculty of Medicine, Osmangazi University, Eskisehir, Turkey; lTepecik Training and Research Hospital, Izmir, Turkey; mErzurum Regional Training and Research Hospital, Erzurum, Turkey; nCerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey; oFaculty of Medicine, Sakarya University, Sakarya, Turkey
hrp0084p3-1017
Vitamin D in Short Children on GH Therapy: Effects of Vitamin D Status and Vitamin D Supplementation on Glucose Homeostasis
aDepartement of Pediatric Endocrinology, C.I.Parhon National Institute of Endocrinology, Bucuresti, Romania; bDepartement OF Scientific Research, C.I.Parhon National Institute OF Endocrinology, Bucuresti, Romania
hrp0084p3-1018
Laron Syndrome Caused by a Large Deletion in GH Receptor Gene
aDepartment of Pediatric Endocrinology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, Istanbul, Turkey; bDepartment of Medical Genetics, Marmara University, Istanbul, Turkey; cDepartment of Pediatric Endocrinology, Kocaeli University, Kocaeli, Turkey
hrp0084p3-1019
Alterations of SHOX and Its Enhancers as a Cause of Short Stature: Evolution of Our Cases
aHospital Universitario Marques De Valdecilla, Santander (Cantabria), Spain; bInstituto De Genética Médica Y Molecular (Ingemm). Hospital Universitario La Paz., Madrid, Spain
hrp0084p3-1023
New Point Mutation in Short Stature Homeobox Gene Leads to Phenotype of Lery-Weill Dyschondrosteosis
aDepartment of Pediatrics, Wilhelmina Children’s Hospital, Utrecht, The Netherlands; bDepartment of Pediatrics, St. Antonius Hospital, Nieuwegein, The Netherlands; cDepartment of Clinical Genetics, Wilhelmina Children’s Hospital, Utrecht, The Netherlands
hrp0084p3-1025
Fasting and Post-Meal Levels of Appetite Regulating Hormones, before and Following GH Treatment, in Children with Idiopathic Short Stature
aThe Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel; bSackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel; cFelsenstein Medical Research Center, Petah Tikva, Israel
hrp0084p3-1026
Impact of Using WHO vs National Growth Charts on the Clinical Performance of a Decision Rule for Growth Monitoring
aINSERM U1153, Equipe de recherche sur les Origines précoces de la santé et du développement de l’enfant (ORCHAD), Centre de Recherche Epidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), Univ, Paris, France; bINSERM U1153, Equipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Epidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), Université Paris De, Paris, France; cDepartment of General Pediatrics, Necker Children’s Hospital, AP-HP, Paris, France; dUnité d’Endocrinologie Pédiatrique, Fondation Ophtalmologique Adolphe de Rothschild, Université Paris Descartes, Paris, France; eAssociation Française de Pédiatrie Ambulatoire, Gradignan, France
hrp0084p3-1027
Comparison of the Performance of Algorithms Proposed to Standardize Growth Monitoring
aINSERM U1153, Equipe de recherche sur les Origines précoces de la santé et du développement de l’enfant (ORCHAD), Centre de Recherche Epidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), University, Paris, France; bINSERM U1153, Equipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Epidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), Université Paris De, Paris, France; cDepartment of General Pediatrics, Necker Children’s Hospital, AP-HP, Paris, France; dUnité d’Endocrinologie Pédiatrique, Fondation Ophtalmologique Adolphe de Rothschild, Université Paris Descartes, Paris, France; eAssociation Française de Pédiatrie Ambulatoire, Gradignan, France
hrp0084p3-1028
Impact of Recombinant Human GH on Height in Children with Chronic Kidney Disease
aDepartment of Pediatrics, Medical Univerisity-Sofia, Sofia, Bulgaria; bDepartment of Internal Medicine, Medical Univerisity-Sofia, Sofia, Bulgaria
hrp0084p3-1032
Birth Length and Metabolic Syndrome in Obese Children
aOspedale Pediatrico Bambino Gesù, Rome, Italy; bUniversita degli studi di Roma Tor Vergata, Rome, Italy; cKarolinska Institutet, Stockholm, Sweden
hrp0084p3-1033
Birth Characteristics Influence the Male to Female Diagnostic Prevalence of Idiopathic GH Deficiency
aEndocrine Care, Pfizer Inc, New York, USA; bPfizer Health AB, Sollentuna, Sweden; cHospital Das Clinicas, University of Sao Paulo, Sao Paulo, Brazil; dUniversity Children’s Hospital, Tubingen, Germany
hrp0084p3-1034
Two Cases with Decelerated Linear Growth, Normal GH - IGF1 Axis with an Exceptional Response to GH Therapy
aHamad Medical Hospital, Doha, Qatar; bAlexandria University, Alexandria, Egypt
hrp0084p3-1035
Impact of GH Treatment in Children Final Height and Weight Status
aEndocrinology, Diabetes and Metabolism Department, Coimbra Hospital and University Centre, Coimbra, Portugal; bPediatric Department, Baixo Vouga Hospital Centre, Aveiro, Portugal; cEndocrinology, Diabetes and Nutrition Department, Baixo Vouga Hospital Centre, Aveiro, Portugal; dEndocrinology, Diabetes and Growth Unit, Pediatric Hospital, Coimbra Hospital and University Centre, Coimbra, Portugal
hrp0084p3-1036
Expanding the Role of Nurses in Improving Patient Care and Clinical Outcomes in Growth Disorders
aBirmingham Children’s Hospital, Birmingham, UK; bCincinnati Children’s Hospital, Cincinnati, OH, USA; cOn Behalf of a Global Nurse Advisory Group,…, Switzerland
hrp0084p3-1037
Short Stature in a Rare 15q Duplication - is hGH Treatment Beneficial?
aDepartment of Endocrinology, University of Medicine and Pharmacy ‘Gr.T.Popa’, Iasi, Romania; bDepartment of Genetics, University of Medicine and Pharmacy ‘Gr.T.Popa’, Iasi, Romania; cDepartment of Endocrinology, Emergency Hospital, Bacau, Romania
hrp0084p3-1038
Psychomotor Development in Children Born Small for Gestational Age During Early Infancy
aAndrea Prader Center, Gov. of Aragón, Zaragoza, Spain; bNeonatology, Miguel Servet University Hospital, Zaragoza, Spain; cEndocrinology, Miguel Servet University Hospital, Zaragoza, Spain
hrp0084p3-1040
Patient with Classic Phenotype of Hypochondroplasia and Deletion of the Gene SHOX
aHospital Vall d’Hebrón, Barcelona, Spain; bHospital de Mataró, Mataró, Barcelona, Spain
hrp0084p3-1041
GH Treatment in Survivors of Paediatric Brain Tumors
aDepartment of Pediatric Endocrinology, Ege University, Izmir, Turkey; bDepartment of Pediatric Oncology, Ege University, Izmir, Turkey; cDepartment of Neurosurgery, Ege University, Izmir, Turkey
hrp0084p3-1042
GH Deficiency in a Patient with 4p16 Deletion: An Infrequent Association with Wolf-Hirschhorn Syndrome
aFirst Department of Pediatrics, P. & A. Kyriakou Children’s Hospital, Athens, Greece; bDivision of Medical Genetics, Aghia Sophia Children’s Hospital, National and Kapodistrian University of Athens, Athens, Greece
hrp0084p3-1043
Value of Alkaline Phosphatase Assay in Short Stature Exploration
Endocrinology Unit, Department of Pediatrics, University Hospital of Rouen, Rouen, France
hrp0084p3-1044
Small for Gestational Age Incidence in One of the Regions of the Russian Federation
Izhevsk State Medical Academy, Izhevsk, Udmurt Republic, Russia
hrp0084p3-1045
Congenital Heart Disease and its Effects on Growth in Children
aUniversity of Medicine and Pharmacy, Craiova, Romania; bClinical Emergency Hospital, Craiova, Romania
hrp0084p3-1047
A Rare Cause of Short Stature: the Floating Harbor Syndrome
aPaediatric Endocrinology Unit, Victor Jousselin Hospital, Dreux, France; bUnité de Recherche Clinique URC28, Victor Jousselin Hospital, Dreux, France
hrp0084p3-1048
Correlations Between IGF1 Levels and Anthropometrical Parameters in Children Under GH Therapy
aDepartment of Endocrinology, Mures County Hospital, Targu Mures, Romania; bDepartment of Endocrinology, University of Medicine and Pharmacy Targu Mures, Targu Mures, Romania
hrp0084p3-1049
BMI and Total Cholesterol are Negative Predictors of Peak Stimulated GH in Han Children with Short Stature
Nanjing Children’s Hospital, Nanjing Medical University, Nanjing, China
hrp0084p3-1050
A 4-Month-Old Boy with Beckwith Wiedemann Syndrome
aMedical Faculty Skopje, University Children’s Hospital, Skopje, Macedonia; bBioscientia Institute for Medical Diagnostics, Center for Human Genetics, Ingelheim, Germany
hrp0084p3-1051
MEGHA: Observational Study on Prescription of the GH Saizen in Adults in France
aHôpital Claude Huriez, CHRU de Lille, Lille, France; bHôpital Neurologique Pierre Wertheimer, CHU de Lyon, Lyon, France; cMerck Serono S.A.S, Lyon, France; dHôpital de l’Archet, CHU de Nice, Nice, France; eCHU de Bicêtre, AP-HP, Paris, France; fHôpital Necker Enfants Malades, AP-HP, Paris, France
hrp0084p3-1052
Comparative Study of Low-Dose GH Treatment in Children with Idiopathic Short Stature and GH Deficiency
aSchool of Medicine, Gyengsang National University, Jinju, Republic of Korea; bSchool of Medicine, Ajou University, Suwon, Republic of Korea; cSchool of Medicine, Hayllm University, Dongtan, Republic of Korea; dKorea Cancer Center Hospital, Seoul, Republic of Korea
hrp0084p3-1053
To Investigate the Changes of Hormone Levels and Body Composition in Pubertal Children with Growth Retardation: a Clinical Controlled Study
Department of Endocrinology, Nanjing Children’s Hospital, Nanjing Medical University, Nanjing, China
hrp0084p3-1054
The Effect of BMI in Reducing Risk of Refractory Seizure due to Probable Lipoid Tissue Factors
School of Medicine, Pediatric Growth Disorders Research Center, 17th Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran
hrp0084p3-1055
GH Treatment for Idiopathic Short Stature
Yerevan State Medical University, Yerevan, Armenia
hrp0084p3-1056
The Frequency Study and the Aetiological Profile of Short Stature in 2-15 Years Old Children Admitted in Endocrinology Clinic of 17 Shahrivar Hospital, Rasht, Between 2008 and 2013
School of Medicine, Pediatrics Growth Disorders Research Center, 17 Shahrivar Hospital, Guilan University of Medical Sciences, Rasht, Iran
hrp0084p3-1057